Thromboelastography and routine coagulation tests in the management of coagulation during ECMO therapy: a comparative study
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 6
Abstract
Objective To investigate the correlation and consistency between the parameters of thromboelastography(TEG) and routine coagulation tests, and to evaluate the application value of the two methods in heparin anticoagulation monitoring and coagulation function monitoring in patients receiving extracorporeal membrane oxygenation(ECMO) therapy. Methods A total of 138 patients who recieved ECMO in the Department of Critical Care Medicine of the People′s Hospital of Guangxi Zhuang Autonomous Region from October 2021 to December 2022 were selected. A total of 317 pairs of ordinary TEG and heparinase-modified TEG(hmTEG) parameters measured simultaneously were analyzed for correlation and consistency with activated partial thromboplastin time(APTT), fibrinogen(Fib), and platelet count(Plt), and the parameters tested when ECMO was established and 24 hours after ECMO operation were compared. Results The correlation coefficient between R values and APTT of hmTEG(r=0.441, P<0.05) was lower than that of ordinary TEG(r=0.547, P<0.05). The parameters α-Angle and K value of ordinary TEG were not correlated with Fib(P>0.05), while as for hmTEG, the correlation was 0.359(P<0.05) and -0.343(P<0.05), respectively. The correlation between MA value of hmTEG and Plt was 0.456(P<0.05), which was much lower than its correlation with Fib(r=0.715, P<0.05). APTT and hmTEG had moderate agreement in judging the anticoagulant effect of UFH(P<0.05). Plt at 24 hours after ECMO was significantly lower than that at establishment of ECMO(P<0.05). Fib, APTT and hmTEG parameters were not significantly different between the two groups(P>0.05). Conclusion The parameters of hmTEG can better reflect the real level of coagulation factors in patients receiving ECMO. The results of hmTEG and APTT are complementary to assess whether heparin in ECMO patients is overdosed, and hmTEG has unique advantages. Routine coagulation tests and TEG cannot replace each other, and the combination of them can achieve better anticoagulation and coagulation management.
Authors and Affiliations
Hao LI, Sina LI, Huini HUANG, Ziji YANG, Huiqiong XIE, Ruixian LUO, Shulin XIANG, Hailan LI, Zhuning MO
Keywords
Related Articles
- EP ID EP742776
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.06.001
- Views 13
- Downloads 0
Changes of specific antibody and neutralizing antibody after voluntary blood donors received COVID-19 vaccine
Objective To analyze the changes in antibody titer of voluntary blood donors after receiving the COVID-19 vaccine, so as to provide reference for blood donation strategy, follow-up vaccine development and COVID-19 preven...
Analysis of guiding value and effect of TEG in clinical application of cryoprecipitation
Objective To retrospectively analyze the guiding significance and effect of thromboelogram (TEG) in the clinical use of cryoprecipitation. Methods A total of 289 patients with fibrinogen reduction, admitted to our hospit...
Validation of detection method for tributyl phosphate residue in human prothrombin complex
Objective To establish gas chromatography for the determination of tributyl phosphate(TBP) residues in human prothrombin complex and then verify it. Methods Acid modified polyethylene glycol(PEG)(20M) capillary column wa...
Causes of ABO forward and reverse grouping discrepancy: 75 cases
Objective To analyze the causes and solutions of ABO forward and reverse grouping discrepancy, and to ensure the safety of blood transfusion in clinical. Methods Samples from 75 patients with discrepancy between forward...
Analysis of donation related vasovagal reactions in Hefei
Objective To explore the influencing factors and characteristics of blood donation-related vasovagal reactions in whole blood donation in Hefei city, and to put forward specific prevention measures. Methods Whole blood d...